Jump to contentThank you for registeringPlease refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged inAllNewsSportCultureLifestyleTrump speaks before an executive order signing regarding Medicare at Sharon L. Morse Performing Arts Center October 3, 2019 (AFP/Getty)The Trump administration will end a temporary Medicare Part D premium subsidy in 2027, a move expected to raise prescription drug insurance costs for millions of older Americans.The Centers for Medicare & Medicaid Services says the program, introduced to stabilize premiums, will expire after costing the federal government about $3.6 billion a year.Roughly 25 million Medicare beneficiaries benefited from the subsidy, which lowered monthly premiums by an average of $16.Health policy experts warn some seniors could see their monthly drug plan premiums jump by as much as $20, with higher costs potentially pushing more people into Medicare Advantage plans.The decision comes as many Americans continue to grapple with rising healthcare costs, creating a potential political headache for President Donald Trump as he tries to maintain support among older voters. In fullOlder Americans set to see Medicare cost rise after Trump kills subsidy for drug programMore bulletinsThank you for registeringPlease refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in

Donald Trump is planning to end a Medicare subsidy program.

Federal subsidies that have helped defray insurers' Medicare drug costs will disappear at the end of the year. Millions of beneficiaries could face higher premiums in 2027.

The Trump administration will end a Medicare Part D subsidy program after 2026. Insurers have gained enough experience to price plans accurately without this support. CMS…

The subsidies are set to end a year ahead of schedule

Millions could face steeper monthly costs

CMS said it will soon no longer provide Medicare Part D, or federal subsidies meant to keep premiums stable for prescription drug plans.